Cancer Immunol Res
-
Publication Venue For
- Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL.. 7:644-657. 2019
- Computational Immune Monitoring Reveals Abnormal Double-Negative T Cells Present across Human Tumor Types.. 7:86-99. 2019
- Stromal Fibroblasts Mediate Anti-PD-1 Resistance via MMP-9 and Dictate TGFβ Inhibitor Sequencing in Melanoma.. 6:1459-1471. 2018
- A Blueprint to Advance Colorectal Cancer Immunotherapies.. 5:942-949. 2017
- CAR T Cells Targeting Podoplanin Reduce Orthotopic Glioblastomas in Mouse Brains.. 4:259-268. 2016
- Complement Factor H Antibodies from Lung Cancer Patients Induce Complement-Dependent Lysis of Tumor Cells, Suggesting a Novel Immunotherapeutic Strategy.. 3:1325-1332. 2015
- Melanoma-Derived Wnt5a Promotes Local Dendritic-Cell Expression of IDO and Immunotolerance: Opportunities for Pharmacologic Enhancement of Immunotherapy.. 3:1082-1095. 2015
- Survival Outcomes of Sipuleucel-T Phase III Studies: Impact of Control-Arm Cross-Over to Salvage Immunotherapy.. 3:1063-1069. 2015
- Severe adverse immunologic reaction in a patient with glioblastoma receiving autologous dendritic cell vaccines combined with GM-CSF and dose-intensified temozolomide.. 3:320-325. 2015
- Peptide/MHC tetramer-based sorting of CD8⁺ T cells to a leukemia antigen yields clonotypes drawn nonspecifically from an underlying restricted repertoire.. 3:228-235. 2015
- CALGB 150905 (Alliance): rituximab broadens the antilymphoma response by activating unlicensed NK cells.. 2:878-889. 2014
- Tumor MHC class I expression improves the prognostic value of T-cell density in resected colorectal liver metastases.. 2:530-537. 2014
- Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome.. 2:332-340. 2014
- Severe cutaneous and neurologic toxicity in melanoma patients during vemurafenib administration following anti-PD-1 therapy.. 1:373-377. 2013
- Temperature matters! And why it should matter to tumor immunologists.. 1:210-216. 2013
- Human regulatory T cells kill tumor cells through granzyme-dependent cytotoxicity upon retargeting with a bispecific antibody.. 1:163. 2013